Fondazione Casa Sollievo della Sofferenza, Department of Medical Sciences, Geriatric Unit, San Giovanni Rotondo, Foggia, Italy.
The BioRobotics Institute, Scuola Superiore Sant'Anna, Pontedera, Italy.
J Alzheimers Dis. 2019;68(4):1587-1601. doi: 10.3233/JAD-181165.
In the EU funded MARIO project, specific technological tools are adopted for the people living with dementia (PLWD). In the final stage of the project, a validation of the MARIO companion robot was performed from August to October 2017.
The aims of the present study are: 1) to illustrate the key results and evidence obtained in the final evaluation phase of the project across the three different pilot sites; 2) to assess the engagement dimensions of the PLWD who interacted with the MARIO robot; and 3) to assess the acceptability and efficacy of the MARIO companion robot on clinical, cognitive, neuropsychiatric, affective and social aspects, resilience, quality of life in PLWD, and burden level of the caregivers.
38 people (M = 14; F = 24) with Alzheimer's disease were screened for eligibility and all were included. The following tests were administered Pre and Post interactions with MARIO: Observational Measurement of Engagement (OME), Mini-Mental State Examination (MMSE), Clock Drawing Test (CDT), Frontal Assessment Battery (FAB), Neuropsychiatric Inventory (NPI), Cornell Scale for Depression in Dementia (CSDD), Multidimensional Scale of Perceived Social Support (MSPSS), 14-item Resilience Scale (RS-14), Quality of Life in Alzheimer's Disease (QOL-AD), Caregiver Burden Inventory (CBI), Tinetti Balance Assessment (TBA), and Comprehensive Geriatric Assessment (CGA) was carried out.
In Post-MARIO interactions, significant improvements were observed in RS-14 (p = 0.020).Considering the age of the people, PLWD with 68-76 years perceived that they had major social support (MSPSS Total: p = 0.016) and friends to support them (MSPSS Fri: p = 0.014). Indeed, the younger people (55-67 years) were less depressed (CSDD: p = 0.033), and more resilient (RS-14: p = 0.003). The people aged 77-85 years perceived they had major family support (MSPSS Fam: p = 0.018). The participants were gender and education matched without any statistically significant difference.
MARIO may be a useful tool in mitigating depression and loneliness, while enhancing social connectedness, resilience, and overall quality of life for people with dementia.
在欧盟资助的 MARIO 项目中，为患有痴呆症的人（PLWD）采用了特定的技术工具。在项目的最后阶段，从 2017 年 8 月到 10 月，对 MARIO 伴侣机器人进行了验证。
本研究的目的是：1）说明在三个不同试点地点的项目最后评估阶段获得的关键结果和证据；2）评估与 MARIO 机器人互动的 PLWD 的参与维度；3）评估 MARIO 伴侣机器人在临床、认知、神经精神病学、情感和社会方面、韧性、PLWD 的生活质量以及照顾者的负担水平方面的可接受性和疗效。
对 38 名符合条件的阿尔茨海默病患者进行了筛选（M = 14；F = 24），并全部纳入。在与 MARIO 互动之前和之后进行了以下测试：参与观察量表（OME）、简易精神状态检查（MMSE）、画钟测验（CDT）、额叶评估量表（FAB）、神经精神病学问卷（NPI）、康奈尔抑郁量表在痴呆症中的应用（CSDD）、多维感知社会支持量表（MSPSS）、14 项韧性量表（RS-14）、阿尔茨海默病生活质量量表（QOL-AD）、照顾者负担量表（CBI）、Tinetti 平衡评估量表（TBA）和综合老年评估量表（CGA）。
在 MARIO 互动后的评估中，RS-14 显著改善（p = 0.020）。考虑到患者的年龄，68-76 岁的 PLWD 认为他们有主要的社会支持（MSPSS 总分：p = 0.016）和朋友支持他们（MSPSS Fri：p = 0.014）。事实上，年轻患者（55-67 岁）抑郁程度较低（CSDD：p = 0.033），韧性更强（RS-14：p = 0.003）。77-85 岁的患者认为他们有主要的家庭支持（MSPSS Fam：p = 0.018）。参与者的性别和教育程度相匹配，没有统计学上的显著差异。
MARIO 可能是一种有用的工具，可以减轻痴呆症患者的抑郁和孤独感，同时增强他们的社交联系、韧性和整体生活质量。
